Not applicableStudy completedNCT04973280
What this trial is testing
Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
Who this might be right for
Myelodysplastic SyndromesBeta-thalassemia
Celgene 187